Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Phase IIa dose-exploration study of JMKX000189 in moderate to severe active systemic lupus erythematosus
ChiCTR2300072438Phase 2Not yet recruiting
- Sponsor
- Peking Union Medical College Hospital
- Start
- Sep 2023
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 2, randomised, double-blind trial of JMKX000189 in systemic lupus erythematosus (SLE) (3 arms), sponsored by Peking Union Medical College Hospital. Primary endpoint: Peripheral blood lymphocyte count. Planned start Sep 2023; status: not yet recruiting.
02
Drugs
JMKX000189
03
Conditions
systemic lupus erythematosus (SLE)
Beyond the preview
Go deeper on ChiCTR2300072438.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on ChiCTR2300072438.